CD274 and neoplasm: 7/66 specimens (10.6%) showed high PDL1 expression on tumor cells (> 50%); 12/66 cases (18.2%) showed intermediate expression (10–40%), and 47/66 cases (71.2%) had a PDL1 expression < 10%.